Skip to main content
Equibles
LLY logo

LLY · ELI LILLY & Co

Track LLY — free

Use LLY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1,149.36 -10.24 (-0.88%) At close · Sep 4
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$1.09T
Shares
941.36M

LLY metrics

79 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1,149.36
Market cap
$1.09T

Price action

19 metrics
Price change (1W)
-1.4%
Price change (30D)
-2.7%
Price change (3M)
+3.1%
Price change (6M)
+17.9%
Price change (YTD)
+7.9%
Price change (1Y)
+57.2%
Trailing year
Price change (5Y)
+346.8%
52-week high
$1,280.34
52-week low
$714.59
Change from 52-week high
-9.4%
Change from 52-week low
+62.3%
Annualized volatility
35.8%
Beta
0.4
RSI (14D)
43.3
Price vs SMA 50
-2.6%
Price vs SMA 200
+9.1%
Avg volume (3M)
2.88M
Relative volume
0.9
Average dollar volume
$3.39B

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
941.36M

Valuation

12 metrics
P / E (TTM)
38.9
Trailing earnings · reciprocal yield 2.6%
PEG ratio
1.5
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
13.7×
reciprocal yield 7.3%
P / book
32.2
reciprocal yield 3.1%
FCF yield
—
TTM · current market cap
Buyback yield
0.6%
P / FCF
—
P / operating cash flow
38.9
reciprocal yield 2.6%
Earnings yield
2.4%

Historical valuation

8 metrics
P / E historical average (3Y)
73.6×
reciprocal yield 1.4%
P / E historical average (5Y)
64.4×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
16.6×
reciprocal yield 6.0%
EV / revenue historical average (5Y)
14.0×
reciprocal yield 7.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.6%
Trailing 12 months
Payout ratio
21.7%
Shareholder yield
1.1%
Dividend / share (TTM)
$6.69
Dividend growth YoY
+15.3%
Dividend growth streak
5
Last ex-dividend
2026-08-14

Earnings calendar

2 metrics
Next earnings
2026-10-29
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
83.4%
Operating margin
—
Trailing 12 months
Net margin
33.5%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$26.71B
Trailing 12 months
Diluted EPS (TTM)
$29.80
FCF margin
—
Effective tax rate
20.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+47.7%
Year over year
Net income growth YoY
+25.3%
Revenue (TTM)
$79.67B
Trailing 12 months
EPS growth YoY
+26.2%
Shares change YoY
-0.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+31.7%
Revenue CAGR (5Y)
+21.6%
EPS CAGR (3Y)
+49.3%
EPS CAGR (5Y)
+27.6%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
78.8%
Return on assets
18.8%
Debt / equity
1.6
Current ratio
1.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$8.95B
Total assets
$142.28B
Total debt
$54.91B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$28.08B
Capital expenditures (TTM)
—
R&D (TTM)
$14.60B
SG&A (TTM)
$12.24B
Stock compensation (TTM)
$649.00M
R&D / revenue
18.3%
Stock compensation / revenue
0.8%

Ownership (13F)

3 metrics
13F filers
4,641
13F filer change QoQ
+248
Institutional ownership
86.8%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 2.1 days to cover
Days to cover
2.1d
Short-squeeze score
36 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$18.84M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 59478 CUSIP 532457108 13F (30d) 2084 filings 1985 filers Visit website Investor relations